Back to all studios
D4 BioVentures (D4 Bioventures) logo

D4 BioVentures (D4 Bioventures)

Venture Studio + Corporate Advisory
Level 53, 25 Martin Place, Sydney NSW 2000, Australia

Industry Focus

Drugs (Small Molecule and Biologic Therapeutics)Devices (Wearable and Implantable Medical Devices)Diagnostics (In Vitro Diagnostic Products)Digital Health (Transformative Digital Health Solutions)BiotechMedtechHealthtechLife SciencesPrecision MedicineAI in HealthcareGenomics and BioinformaticsMedical IoTNeurotechnologyBioelectronic MedicineMedical ImagingWearable SensorsRadiopharmaceuticalsTheranostics

Geographic Focus

AustraliaSydneyNew South WalesQueenslandVictoriaSingaporeUnited StatesEurope

D4 BioVentures is a venture studio and boutique corporate advisory firm dedicated to transforming life science and healthcare innovations into well-funded, market-ready enterprises. Formed as a strategic joint venture between SWG Capital and life sciences experts David Barda and Dr. Steven Suchting, D4 specializes in venture building for universities and medical research institutes across Australia, and provides capital raising and corporate structuring services for life science and health sector companies. Following a successful pilot running the Garvan Venture Studio, D4 focuses on assisting universities and medical research institutes to convert their innovations into funded, market-ready spinouts. The organization's name reflects its focus on the four key domains of biomedical innovation: Drugs, Devices, Diagnostics, and Digital Health. D4 combines deep domain expertise in life sciences with financial acumen from investment banking and corporate law backgrounds.

Founded

2023

Portfolio

5 Companies

Partners

4